Insider Trading disclosures for Elevai Labs Inc.
The latest disclosure was made by Braeden Lichti in Elevai Labs Inc. where a trade of 3,336,437
Series B Preferred Stock done
was reported to US exchanges on March 26, 2025.
Insider trading is the trading of a company’s securities by individuals with access to confidential or material non-public information about the company.
A company is required to report trading by corporate officers, directors, or other company members with significant access to privileged information to the Securities and Exchange Commission (SEC).
| Client Name |
Client Category |
Action |
Reported to Exchange |
Quantity |
Post Transaction Holding |
Traded % |
Avg. Price |
Value |
Security Type |
|
Braeden Lichti
|
Director, Ten Percent Owner |
Grant, award, or other acquisition of securities at price $ 0.00 per share. |
26 Mar 2025 |
3,336,437 |
3,336,437
|
-
|
|
0
|
Series B Preferred Stock |
|
Graydon Bensler
|
Director, CEO & CFO, Ten Percent Owner |
Grant, award, or other acquisition of securities at price $ 0.00 per share. |
26 Mar 2025 |
3,036,437 |
3,036,437
|
-
|
|
0
|
Series B Preferred Stock |
*All Values are in $ Million
Client Category: Promoter/ KMP/ Director / Immediate Relatives / Employee / etc
Security Type: Share/ Warrants / Convertible Debentures
Data as reported to USA Exchanges